Cardiovascular Risk and Statin Use in the United States

被引:62
|
作者
Johansen, Michael Edward [1 ,2 ]
Green, Lee A. [2 ,3 ]
Sen, Ananda [2 ,4 ]
Kircher, Sheetal [5 ]
Richardson, Caroline R. [2 ,6 ,7 ]
机构
[1] Ohio State Univ, Dept Family Med, Columbus, OH 43201 USA
[2] Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA
[3] Univ Alberta, Dept Family Med, Edmonton, AB T6G 2M7, Canada
[4] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA
[5] Northwestern Univ, Dept Internal Med Hematol Oncol, Evanston, IL USA
[6] VA Ann Arbor Hlth Care Syst, Ann Arbor, MI USA
[7] VA Ctr Clin Management Res, Ann Arbor, MI USA
关键词
cardiovascular: coronary artery disease; cardiovascular: hyperlipidemia; endocrinology: diabetes; primary care issues; CORONARY-HEART-DISEASE; PRIMARY PREVENTION; LOWERING TREATMENT; CHOLESTEROL; THERAPY; PEOPLE; METAANALYSIS; MORTALITY; TRENDS; TRIALS;
D O I
10.1370/afm.1641
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
PURPOSE Statins reduce the risk of mortality and coronary artery disease in individuals at high cardiovascular risk. Using nationally representative data, we examined the relationships between statin use and cardiovascular risk, diagnosis of hyperlipidemia, and other risk factors. METHODS We analyzed data from the 2010 Medical Expenditure Panel Survey, a nationally representative survey of the US civilian noninstitutionalized population. The study sample had a total of 16,712 individuals aged 30 to 79 years. Those who reported filling at least 2 statin prescriptions were classified as statin users. We created multiple logistic regression models for statin use as the dependent variable, with cardiovascular risk factors and sociodemographic factors as independent variables. RESULTS Overall, 58.2% (95% CI, 54.6%-61.7%) of individuals with coronary artery disease and 52.0% (95% CI, 49.4%-54.6%) of individuals with diabetes aged older than 40 years were statin users. After adjusting for cardiovascular risk factors and sociodemographic factors, the probability of being on a statin was significantly higher among individuals with both hyperlipidemia and coronary artery disease, at 0.44 (95% CI, 0.40-0.48), or hyperlipidemia only, at 0.32 (95% CI, 0.30-0.33), than among those with coronary artery disease only, at 0.11 (95% CI, 0.07-0.15). A similar pattern was seen in people with diabetes. CONCLUSIONS In this nationally representative sample, many people at high risk for cardiovascular events, including those with coronary artery disease, diabetes, or both, were not receiving statins despite evidence that these agents reduce adverse events. This undertreatment appears to be related to placing too much emphasis on hyperlipidemia and not enough on cardiovascular risk. Recently released guidelines from the American College of Cardiology and the American Heart Association offer an opportunity to improve statin use by focusing on cardiovascular risk instead of lipid levels.
引用
收藏
页码:215 / 223
页数:9
相关论文
共 50 条
  • [1] Statin Use in Children in the United States
    Lasky, Tamar
    [J]. PEDIATRICS, 2008, 122 (06) : 1406 - 1408
  • [2] Statin Use and Eligibility for Primary Prevention of Atherosclerotic Cardiovascular Disease Among Adults at Borderline or Intermediate Risk in the United States
    Hammond, Michael M.
    Cameron, Natalie A.
    Ning, Hongyan
    Bah, Imani
    Beltrame, Kaitlyn
    Khan, Sadiya S.
    Shah, Nilay S.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (08):
  • [3] Statin Use in Children in the United States In Reply
    Greer, Frank R.
    Daniels, Steven R.
    [J]. PEDIATRICS, 2008, 122 (06) : 1408 - 1408
  • [4] Statin use for cardiovascular disease prevention: perceptions among people living with HIV in the United States
    Ogunbajo, Adedotun
    Todd, Ivy
    Zajdman, Deborah
    Anderson, Abraelle
    Wali, Soma
    Diamant, Allison
    Ladapo, Joseph A.
    Ober, Allison J.
    [J]. BMC PRIMARY CARE, 2024, 25 (01):
  • [5] Statin Use Recommendation in Cardiovascular Risk Management Is Controversial
    Mahla, Ranjeet Singh
    [J]. AMERICAN JOURNAL OF MEDICINE, 2019, 132 (12): : E862 - E862
  • [6] Statin Use and Reduced Risk of Death: Experience of United States Veterans 2002-2012
    Wilson, Peter W.
    Lu Bing
    Ho, Yuk-Lam
    Costa, Lauren
    Honerlaw, Jacquline
    Gaziano, J. M.
    Gagnon, David R.
    Djousse, Luc
    Vassy, Jason L.
    Cho, Kelly
    [J]. CIRCULATION, 2018, 138
  • [7] Neighborhood Walkability and Cardiovascular Risk in the United States
    Makhlouf, Mohamed H. E.
    Motairek, Issam
    Chen, Zhuo
    Nasir, Khurram
    V. Deo, Salil
    Rajagopalan, Sanjay
    Al-Kindi, Sadeer G.
    [J]. CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (03)
  • [8] Disparities in Cardiovascular Disease Risk in the United States
    Graham, Garth
    [J]. CURRENT CARDIOLOGY REVIEWS, 2015, 11 (03) : 238 - 245
  • [9] Neighborhood Walkability and Cardiovascular Risk in the United States
    Motairek, Issam
    Makhlouf, Mohamed H. E.
    Nasir, Khurram
    Deo, Salil V.
    Rajagopalan, Sanjay
    Al-Kindi, Sadeer
    [J]. CIRCULATION, 2022, 146
  • [10] Statin use and the risk of incident dementia - The cardiovascular health study
    Rea, TD
    Breitner, JC
    Psaty, BM
    Fitzpatrick, AL
    Lopez, OL
    Newman, AB
    Hazzard, WR
    Zandi, PP
    Burke, GL
    Lyketsos, CG
    Bernick, C
    Kuller, LH
    [J]. ARCHIVES OF NEUROLOGY, 2005, 62 (07) : 1047 - 1051